Pharmafile Logo
Pharmafocus logo
Advanced Search

endometriosis

Showing 7 posts of 7 posts found.

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026
Research and Development Gesynta Pharma, endometriosis

Gesynta Pharma has dosed the first patient in its phase 2 clinical proof-of-concept trial of vipoglanstat. The trial, NOVA, is …

News

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026
Research and Development EndoCyclic Therapeutics, FDA, endometriosis

EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …

News

Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology

July 29, 2025
Medical Communications, Research and Development Open Quantum Institute, Pain, Reproductive health, UN Sustainable Development Goals, United Nations, Universal Quantum, endometriosis, women's health

Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore how quantum computing could revolutionise …

News
Endometriosis - Woman holding stomach in pain

The Problem of Endometriosis in the UK

July 7, 2025
Research and Development NHS, Obstetrics & Gynaecology, Pain, Reproductive health, Theramex, endometriosis, gynaecology

When did we decide it was an acceptable condition of womanhood in the UK to live with chronic pain?

Feature

FDA approves first endometriosis pain management drug in a decade

July 25, 2018
Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma

The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …

News

Bayer in Oxford tie-up

July 11, 2014
Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university

Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …

News
Bayer image

Bayer signs endometriosis pact

October 3, 2012
Research and Development, Sales and Marketing Bayer, Evotec, endometriosis

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026